A PROSPECTIVE STUDY OF EPLEY MANOEUVRE'S EFFICACY IN ENHANCING THE QUALITY OF LIFE OF SUBJECTIVE BENIGN PAROXYSMAL POSITIONAL VERTIGO PATIENTS.

Abstract

Objectives:

The study aimed to assess the impact of Epley maneuver and oral betahistine on the Dizziness Handicap Inventory (DHI) scores in subjective benign paroxysmal positional vertigo (sBPPV) patients, comparing them with those treated with betahistine alone. The objective was to evaluate the 10-day post-treatment improvement in the quality of life for sBPPV patients.

Methods:

A prospective study with 60 participants assessed vertigo complaints using otological examinations, Pure Tone Audiometry, Dix-Hallpike maneuver, and Supine roll test. Participants showing no observable nystagmus were randomly assigned to a Study group receiving Epley maneuver and oral Betahistine or a Control group receiving oral Betahistine alone. The study aimed to compare outcomes in both groups.

Results:

In this study involving 60 patients, the study group exhibited a significant improvement in total functional score, total emotional score, total physical score, and total score from baseline to 10 days post-treatment (p value < 0.05). The mean ± SD of baseline total functional score, total emotional score, total physical score, and total score was 20.93 ± 4.83, 15 ± 4.23, 17.87 ± 5.14, and 53.8 ± 9.60, respectively, significantly higher than the values after 10 days.

Conclusion:

The study demonstrates a significant improvement in Dizziness Handicap Inventory scores, indicating enhanced quality of life in subjective BPPV patients treated with the Epley maneuver and oral betahistine. These findings support the combined therapy as an effective approach in managing subjective BPPV.

Recommendation:

 The study recommends considering the combined treatment of Epley maneuver and oral betahistine for subjective BPPV patients to enhance their quality of life. Further research could explore the long-term efficacy and broader applicability of this intervention.